Monthly Archives: February 2020
ON WORLD SICKLE CELL DAY, MEDUNIK USA HIGHLIGHTS THE IMPORTANCE OF EARLY TREATMENT OF SICKLE CELL DISEASE
19 June 2019 ROSEMONT, PA, June 19, 2019 – This World Sickle Cell Day, Medunik USA, a company dedicated to improving the health and quality of life of Americans with rare diseases, highlights the importance of early treatment of sickle cell disease. “Sickle cell disease is a destructive nemesis. The keys to winning this life-long […]
Read MoreP.O.W.E.R ECHO Project CBO Training starting February 18, 2020
When: Feb 18, 2020 11:00 AM Eastern Time (US and Canada) Register in advance for this meeting: https://echo.zoom.us/meeting/register/vpMtcOGupzgsaf5KlqAhEibOijKXIQxcZQ After registering, you will receive a confirmation email containing information about joining the meeting.
Read MoreFORMA Therapeutics Announces FT-4202 Granted Fast Track Designation and Rare Pediatric Disease Designation for Treatment of Sickle Cell Disease
WATERTOWN, Mass. – February 20, 2020 – FORMA Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on rare hematologic diseases and cancers, today announced the U.S. Food and Drug Administration (FDA) has granted Fast Track designation and Rare Pediatric Disease designation for its lead clinical asset, FT-4202, in development as a disease-modifying treatment for sickle cell […]
Read MoreSCDAA Advocacy Institute April 2021
Our Mission: To advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.
Read MoreSCDAA Leadership Academy – March 19, 2020
Topic: The Dynamics of Fundraising Trainer: Michelle Nusum-Smith Time: March 19, 2020 2:30 pm – 3:30 pm Get in touch with us today! Office location: 7240 Parkway Drive, Suite 180 Hanover, MD 21076 Contact information: (410) 528-1555 Website: www.sicklecelldisease.org
Read More